EasyPGX® is a dry qPCR-based diagnostic test for pharmacogenetic and tumor profiling in oncology. It enables rapid molecular analysis of patient genetic variants to guide precision treatment selection and reduce turnaround time for clinical decision-making.
Manufactured by
Jesi, Italy
Diatech Pharmacogenetics is the Italian leader in the development, production and commercialisation of pharmacogenetics tests for cancer precision medicine. Founded in 1996, Diatech Pharmacogenetics has sustained constant organic growth over the years and now owns more than 70% of the Italian molecular diagnostic market and it is rapidly growing worldwide; to date, more than 20.000 diagnostic tests have been performed using its solutions and every year Diatech Pharmacogenetics reinvests 20% of it revenues in R D. Diatech Pharmacogenetics is able to take pharmacogenetics tests from idea to market on a variety of platforms, from real-time PCR to barcoded microarrays, mass-spectrometry and next generation sequencing, supplying all reagents, instruments, materials and support necessary. Its complete solutions guide diagnostic operators from sample extraction, quality control, molecular assay to bioinformatic analysis and report. The latest products launched include a liquid biopsy cfDNA extraction kit, a real-time PCR system with all reagent provided in a dry and stable format, micro-satellite instability assays and an end-to-end NGS solution that works on both Illumina and IonTorrent platforms. All Diatech products are developed under EN ISO 9001 and EN ISO 13485 and have been designed, developed and validated in accordance with the Directive 98/79/EC on in vitro diagnostic medical devices (CE-IVD).
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept
India · 1 relevant product
Qiagen
United States · 1 relevant product
Aliko Scientific SA
France · 1 relevant product
GENERI BIOTECH s.r.o.
Czech Republic · 5 relevant products
HealthTec Logix
Kuwait · 2 relevant products
Eone-Diagnomics Genome Center
South Korea · 2 relevant products
APPOLON BIOTECK SAS
France · 2 relevant products
Grifols International, S.A
Spain · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 5 relevant products
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 87 closest product alternatives
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine test identifying optimal chemotherapy agents for individual tumors based on molecular characteristics. Guides targeted drug selection and improves treatment efficacy.
3B BlackBio Dx - TRUPCR Europe - CORIS BioConcept · India
PCR-based molecular diagnostic kit for detection of epidermal growth factor receptor mutations in solid tumors. Supports personalized cancer treatment planning and targeted therapy selection.
Qiagen · United States
A diagnostic test for oncology applications designed to detect genetic variations in solid tumors. It supports cancer research and precision oncology workflows.
Aliko Scientific SA · France
Advanced genetic testing platform for cancer diagnosis and personalized medicine applications. The system has been validated across thousands of real-world clinical scenarios for reliability and accuracy.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for pharmacogenomic testing of DPYD gene polymorphisms (*2A, *13, HapB3, c2846A>T). Enables genotyping to guide personalized drug dosing and reduce adverse drug reactions in cancer therapy. Uses fluorescently-labeled probes for accurate allelic discrimination.
HealthTec Logix · Kuwait
Comprehensive genomic diagnostic platform providing precision analysis for disease detection and personalized treatment planning. Integrates molecular-based technologies with clinical interpretation for accurate patient stratification.
Eone-Diagnomics Genome Center · South Korea
Liquid biopsy diagnostic platform for comprehensive genomic analysis and disease screening. Enables detection of genetic markers and abnormalities through blood-based testing.
APPOLON BIOTECK SAS · France
In vitro diagnostic devices for oncology applications focusing on genetic mutation detection and biomarker analysis. Supports clinical decision-making through comprehensive molecular profiling.
Grifols International, S.A · Spain
A genotyping diagnostic solution for disease risk assessment and clinical decision-making.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.
HealthTec Logix · Kuwait
Integrated diagnostic platform combining genomic sequencing with molecular analysis for precision medicine applications. Enables personalized treatment planning and early disease detection.
Medicover Genetics Ltd · Cyprus
Diagnostic genetic testing for pharmacogenomics to guide treatment selection in patients with identified medical conditions. Provides genetic insights for personalized medication management.
75 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products